A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors
Clinical trial NCT06190886 · RECRUITING
Trial details
- NCT number
- NCT06190886
- Sponsor
- Proviva Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-11
- Primary completion
- 2026-05-14
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.